Dongwha Pharm.Co.Ltd (000020) — Cash Flow-to-Debt Ratio
Dongwha Pharm.Co.Ltd (000020) has a Cash Flow-to-Debt Ratio of 0.04x as of December 2025, meaning its operating cash flow of ₩9.70 Billion could theoretically repay 0% of its total liabilities (₩240.73 Billion) in one year. See 000020 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Dongwha Pharm.Co.Ltd Cash Flow-to-Debt Ratio (2011–2025)
Historical debt coverage capacity for Dongwha Pharm.Co.Ltd across 15 annual periods. Also explore Dongwha Pharm.Co.Ltd (000020) net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Dongwha Pharm.Co.Ltd (2011–2025)
Year-by-year debt coverage analysis for Dongwha Pharm.Co.Ltd. For market capitalisation and broader financial context, see 000020 market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.07x | ₩15.70 Billion | ₩240.73 Billion | ▲ +455.1% |
| 2024 | -0.02x | ₩-4.00 Billion | ₩217.96 Billion | ▼ -109.9% |
| 2023 | 0.18x | ₩29.17 Billion | ₩157.92 Billion | ▼ -47.9% |
| 2022 | 0.35x | ₩29.22 Billion | ₩82.46 Billion | ▼ -13.8% |
| 2021 | 0.41x | ₩36.03 Billion | ₩87.67 Billion | ▼ -28.3% |
| 2020 | 0.57x | ₩52.23 Billion | ₩91.13 Billion | ▲ +224.2% |
| 2019 | 0.18x | ₩13.28 Billion | ₩75.15 Billion | ▲ +396.8% |
| 2018 | -0.06x | ₩-4.36 Billion | ₩73.20 Billion | ▲ +74.7% |
| 2017 | -0.24x | ₩-16.52 Billion | ₩70.28 Billion | ▼ -166.1% |
| 2016 | 0.36x | ₩25.48 Billion | ₩71.68 Billion | ▲ +56.1% |
| 2015 | 0.23x | ₩19.83 Billion | ₩87.07 Billion | ▲ +40.5% |
| 2014 | 0.16x | ₩13.51 Billion | ₩83.35 Billion | ▲ +75.8% |
| 2013 | 0.09x | ₩8.21 Billion | ₩88.93 Billion | ▼ -64.4% |
| 2012 | 0.26x | ₩25.23 Billion | ₩97.29 Billion | ▼ -38.4% |
| 2011 | 0.42x | ₩46.24 Billion | ₩109.81 Billion | — |